ROC analysis was performed to evaluate the sensitivity and specificity of BLACAT1 as a diagnostic marker in BC patients, the area under the curve (AUC) was 0.52 with very high specificity (100%) and low sensitivity (51.4%). Here, BLACAT1 is linked to breast cancer.